HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Alex Adjei Selected Research
Alex Adjei Research Topics
Disease
12
Neoplasms (Cancer)
01/2022 - 05/2003
6
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2023 - 12/2005
4
Malaria
01/2020 - 04/2015
2
Nausea
10/2016 - 02/2005
2
Vomiting
10/2016 - 02/2005
2
Lung Neoplasms (Lung Cancer)
03/2013 - 11/2008
2
Carcinoma (Carcinomatosis)
03/2013 - 06/2007
1
Neoplasm Metastasis (Metastasis)
01/2023
1
Falciparum Malaria (Plasmodium falciparum Malaria)
01/2020
1
Body Weight (Weight, Body)
01/2017
1
Exanthema (Rash)
10/2016
1
Fatigue
10/2016
1
Melanoma (Melanoma, Malignant)
10/2016
1
Edema (Dropsy)
10/2016
1
Diarrhea
10/2016
1
Neoplasm Micrometastasis
03/2013
1
Basal Cell Carcinoma (Rodent Ulcer)
09/2011
1
Medulloblastoma
09/2011
1
Small Cell Lung Carcinoma (Small Cell Lung Cancer)
07/2007
1
Prostatic Neoplasms (Prostate Cancer)
06/2007
1
Circulating Neoplastic Cells
06/2007
1
Hot Flashes
01/2006
1
Anemia
02/2005
Drug/Important Bio-Agent (IBA)
3
piperaquine
IBA
01/2020 - 01/2016
3
artenimol (dihydroartemisinin)
IBA
01/2020 - 01/2016
3
Proteins (Proteins, Gene)
FDA Link
03/2013 - 05/2003
2
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
01/2022 - 03/2013
2
Tyrosine Kinase Inhibitors
IBA
01/2019 - 01/2018
2
Erlotinib Hydrochloride (CP 358,774)
FDA Link
01/2019 - 02/2012
2
Biomarkers (Surrogate Marker)
IBA
11/2018 - 06/2007
1
Immune Checkpoint Inhibitors
IBA
01/2023
1
sotorasib
IBA
01/2023
1
cediranib (AZD2171)
IBA
01/2022
1
Vascular Endothelial Growth Factor Receptors (VEGF Receptors)
IBA
01/2022
1
Mitogen-Activated Protein Kinase Kinases (MEKs)
IBA
01/2022
1
AZD 6244
IBA
01/2022
1
JNK Mitogen-Activated Protein Kinases
IBA
12/2021
1
ceritinib
IBA
12/2021
1
Anaplastic Lymphoma Kinase
IBA
12/2021
1
Gemcitabine
FDA Link
12/2021
1
Proto-Oncogene Proteins c-met
IBA
12/2021
1
Farnesyltranstransferase (Farnesyltransferase)
IBA
01/2019
1
tipifarnib (R115777)
IBA
01/2019
1
Epidermal Growth Factor (EGF)
IBA
01/2019
1
Antibodies
IBA
11/2018
1
XL647
IBA
01/2018
1
cobimetinib
IBA
10/2016
1
erionite
IBA
01/2016
1
Mineral Fibers (Mineral Fiber)
IBA
01/2016
1
Asbestos
IBA
01/2016
1
artemisinin (artemisinine)
IBA
04/2015
1
Pemetrexed (MTA)
FDA Link
11/2013
1
human FLT4 protein
IBA
03/2013
1
Carcinoembryonic Antigen
IBA
03/2013
1
Messenger RNA (mRNA)
IBA
03/2013
1
Cell Adhesion Molecules
IBA
03/2013
1
Vascular Endothelial Growth Factors
IBA
03/2013
1
Vascular Endothelial Growth Factor C
IBA
03/2013
1
Vascular Endothelial Growth Factor D
IBA
03/2013
1
Keratin-7 (Cytokeratin 7)
IBA
03/2013
1
Insulin (Novolin)
FDA Link
02/2012
1
Immunoglobulin G (IgG)
IBA
02/2012
1
Monoclonal Antibodies
IBA
02/2012
1
cixutumumab
IBA
02/2012
1
HhAntag691
IBA
09/2011
1
Orosomucoid (Seromucoid)
IBA
09/2011
1
Bevacizumab (Avastin)
FDA Link
01/2008
1
Etoposide (VP 16)
FDA Link
Generic
07/2007
1
Cisplatin (Platino)
FDA Link
Generic
07/2007
1
figitumumab
IBA
06/2007
1
Insulin-Like Peptides
IBA
06/2007
1
Hormones (Hormone)
IBA
06/2007
1
IGF Type 1 Receptor (IGF 1 Receptor)
IBA
06/2007
1
Dehydroepiandrosterone (DHEA)
IBA
01/2006
1
Bilirubin
IBA
02/2005
1
tanespimycin (17AAG)
IBA
02/2005
1
sibrotuzumab
IBA
05/2003
1
Complementarity Determining Regions (Complementarity Determining Region)
IBA
05/2003
Therapy/Procedure
5
Drug Therapy (Chemotherapy)
12/2021 - 12/2005
4
Therapeutics
11/2008 - 12/2005
1
Radiotherapy
07/2007
1
Cranial Irradiation
07/2007
1
Gamma Cameras (Gamma Camera)
05/2003